IJCRR - Vol 07 Issue 20, October, 2015
POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME (PRES) IN PREGNANCY
Author: Pratik J. Mavani, Hina V. Oza, Hafsa M. Vohra
Aims and Objective: Explain association and outcome of Posterior Reversible Encephalopathy Syndrome in Pregnancy.
Method: This is a Retrospective Study based on obstetric patients visited at Civil Hospital, Ahmedabad, Gujarat, India withconvulsion and/or alteration of sensations in the period of 2 YEARS from July 2013 to July 2015. These patients diagnosed as Posterior Reversible Encephalopathy Syndrome with help of MRI Brain. Details of these patients like history, examination and investigation findings recorded and final data analysis done.
Results: All patients with Posterior Reversible Encephalopathy Syndrome had convulsions and alteration of sensations. Development of Posterior Reversible Encephalopathy Syndrome is more common in primigravida, antenatal patients with average age of 21 year. There is increased rate of preterm delivery and Neonatal ICU admissions in neonates which increases morbidity and mortality of babies.
Conclusion: Posterior Reversible Encephalopathy Syndrome develops more commonly in Primigravida Antenatal patients during Third decade of their life. In Posterior Reversible Encephalopathy Syndrome there are increased incidences of unconsciousness, Caesarean delivery, Intensive Care Unit admissions (peripartum morbidity), preterm babies (Neonatal ICU admission) and perinatal mortality. Though Posterior Reversible Encephalopathy Syndrome increases maternal morbidity, no maternal mortality seen.
Keywords: Posterior reversible encephalopathy syndrome, MRI brain
Pratik J. Mavani, Hina V. Oza, Hafsa M. Vohra. POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME (PRES) IN PREGNANCY International Journal of Current Research and Review. Vol 07 Issue 20, October, 41-44
1. Bartynski WS (2008) Posterior reversible encephalopathy syndrome, part 1: fundamental imaging and clinical features. AJNR Am J Neuroradiol 29: 1036–1042.
2. Bartynski WS (2008) Posterior reversible encephalopathy syndrome, part 2: controversies surrounding pathophysiology of vasogenic oedema. AJNR Am J Neuroradiol 29: 1043–1049.
3. Hinchey J, Chaves C, Appignani B, et al (1996) A reversible posterior leukoencephalopathy syndrome. N Engl J Med 334: 494–500.
4. McKinney AM, Short J, Truwit CL, et al (2007) Posterior reversible encephalopathy syn- drome: incidence of atypical regions of involvement and imaging findings. AJR Am J Roentgenol 189: 904–912.
5. Schwartz RB, Bravo SM, Klufas RA, et al (1995) Cyclosporine neurotoxicity and its rela- tionship to hypertensive encephalopathy: CT and MR findings in 16 cases. AJR Am J Roentgenol 165: 627–631.
6. Casey SO, Sampaio RC, Michel E, Truwit CL (2000) Posterior reversible encephalopathy syndrome: utility of fluid-attenuated inversion recovery MR imaging in the detection of cortical and subcortical lesions. AJNR Am J Neuroradiol 21: 1199–1206.
7. Lee VH, Wijdicks EF, Manno EM, Rabinstein AA (2008) Clinical spectrum of reversible posterior leukoencephalopathy syndrome. Arch Neurol 65: 205–210.
8. Burnett MM, Hess CP, Roberts JP, Bass NM, Douglas VC, Josephson SA (2010) Presenta- tion of reversible posterior leukoencephalopathy syndrome in patients on calcineurin inhibitors. Clin Neurol Neurosurg 112: 886–889.
9. Servillo G, Striano P, Striano S, et al (2003) Posterior reversible encephalopathy syndrome (PRES) in critically ill obstetric patients. Intensive Care Med 29: 2323–2326.
10. Kozak OS, Wijdicks EF, Manno EM, Miley JT, Rabinstein AA (2007) Status epilepticus as initial manifestation of posterior reversible encephalopathy syndrome. Neurology 69: 894–897.
11. Bartynski WS, Boardman JF (2007) Distinct imaging patterns and lesion distribution in posterior reversible encephalopathy syndrome. AJNR Am J Neuroradiol 28: 1320–1327.